☰

Robert Lucito - Publications

Affiliations: 
Molecular and Cellular Biology Stony Brook University, Stony Brook, NY, United States 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Cutter NL, Walther T, Gallagher L, Lucito R, Wrzeszczynski K. Abstract A24: Hypoxia signaling pathway plays a role in ovarian cancer chemoresistance. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A24  0.717
2015 Fan G, Wrzeszczynski KO, Fu C, Su G, Pappin DJ, Lucito R, Tonks NK. A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines. The Biochemical Journal. 465: 433-42. PMID 25406946 DOI: 10.1042/Bj20141087  0.519
2015 Chaudhary F, Lucito R, Tonks NK. Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity. The Biochemical Journal. 465: 89-101. PMID 25287652 DOI: 10.1042/Bj20140573  0.407
2015 Moskal D, Tonks NK, Lucito R. Abstract 1933: Alteration of the protein tyrosine phosphatome in cancer Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2015-1933  0.534
2014 Tonks N, Lucito R. Abstract 4178: Global assessment of the protein tyrosine phosphatome in cancer Cancer Research. 74: 4178-4178. DOI: 10.1158/1538-7445.Am2014-4178  0.427
2013 Wrzeszczynski KO, Varadan V, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer. Methods in Molecular Biology (Clifton, N.J.). 1049: 35-51. PMID 23913207 DOI: 10.1007/978-1-62703-547-7_4  0.638
2013 Fan G, Lin G, Lucito R, Tonks NK. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells. The Journal of Biological Chemistry. 288: 24923-34. PMID 23814047 DOI: 10.1074/Jbc.M113.482737  0.433
2013 Rajaram M, Zhang J, Wang T, Li J, Kuscu C, Qi H, Kato M, Grubor V, Weil RJ, Helland A, Borrenson-Dale AL, Cho KR, Levine DA, Houghton AN, Wolchok JD, ... ... Lucito R, et al. Two Distinct Categories of Focal Deletions in Cancer Genomes. Plos One. 8: e66264. PMID 23805207 DOI: 10.1371/Journal.Pone.0066264  0.526
2013 Lum E, Vigliotti M, Banerjee N, Cutter N, Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis. Gynecologic Oncology. 130: 369-76. PMID 23684582 DOI: 10.1016/J.Ygyno.2013.05.002  0.749
2013 Lum E, Vigliotti M, Banerjee N, Cutter N, Kamalakaran S, Wrzeszczynski K, Khan S, Dimitrova N, Levine D, Lucito R. Abstract 2988: DOK2 suppression by methylation induces platinum resistance via suppression of apoptosis in ovarian cancer cells. Cancer Research. 73: 2988-2988. DOI: 10.1158/1538-7445.Am2013-2988  0.761
2013 Wrzeszczynski KO, Fan G, Fu C, Pappin DJ, Lucito R, Tonks NK. Abstract 2502: Proteomic identification of carboplatin resistance in ovarian cancer cells. Cancer Research. 73: 2502-2502. DOI: 10.1158/1538-7445.Am2013-2502  0.596
2013 Wrzeszczynski KO, Fan G, Fu C, Pappin DJ, Lucito R, Tonks NK. Abstract B41: Proteomic characterization of carboplatin resistance in ovarian cancer cells Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B41  0.589
2013 Vigliotti M, Lum E, Banerjee n, Cutter N, Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Abstract A46: Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A46  0.856
2013 Cutter NL, Yacoub M, Lucito RD, Dimitrova N, Lum E, Vigliotti M, Wrzeszczynski K, Levine DA. Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A24  0.863
2012 NLCPD, Lum E, Vigliotti M, Khan S, Levine D, Dimitrova N, Lucito R. Abstract 3144: A role for DOK2 methylation in platinum resistance and tumor suppression in ovarian cancer Cancer Research. 72: 3144-3144. DOI: 10.1158/1538-7445.Am2012-3144  0.838
2012 Cutter N, Vigliotti M, Lum E, Wrzeszczynski KO, Varadan V, Dimitrova N, Levine DA, Lucito R. Abstract 1047: Suppression of the chromatin remodeling protein CHD3 and platinum resistance in ovarian cancer Cancer Research. 72: 1047-1047. DOI: 10.1158/1538-7445.Am2012-1047  0.755
2011 Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. Plos One. 6: e28503. PMID 22174824 DOI: 10.1371/Journal.Pone.0028503  0.815
2011 Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, KÃ¥resen R, Shama Prasada K, Rotti H, Rao R, Rao L, ... ... Lucito R, et al. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Molecular Oncology. 5: 77-92. PMID 21169070 DOI: 10.1016/J.Molonc.2010.11.002  0.499
2011 NLCPD, Banerjee N, Vigliotti M, Janevski A, Levine D, Lucito R, Dimitrova N. Abstract 70: A role for the chromatin remodeling protein CHD3 in ovarian cancer therapy response Cellular and Molecular Biology. 71: 70-70. DOI: 10.1158/1538-7445.Am2011-70  0.485
2011 Wrzeszczynski KO, Varadan V, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R. Abstract 30: Identification of genomic and epigenetic features of tumor suppressors and oncogenes in ovarian cancer Cancer Research. 71: 30-30. DOI: 10.1158/1538-7445.Am2011-30  0.633
2010 Banerjee N, Janevski A, Kamalakaran S, Varadan V, Lucito R, Dimitrova N. Pathway and network analysis probing epigenetic influences on chemosensitivity in ovarian cancer 2010 Ieee International Workshop On Genomic Signal Processing and Statistics, Gensips 2010. DOI: 10.1109/GENSIPS.2010.5719670  0.598
2009 Lucito R, Byrnes J. Comparative genomic hybridization by representational oligonucleotide microarray analysis. Methods in Molecular Biology (Clifton, N.J.). 556: 33-46. PMID 19488870 DOI: 10.1007/978-1-60327-192-9_4  0.517
2009 Kamalakaran S, Kendall J, Zhao X, Tang C, Khan S, Ravi K, Auletta T, Riggs M, Wang Y, Helland A, Naume B, Dimitrova N, Børresen-Dale AL, Hicks J, Lucito R. Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation. Nucleic Acids Research. 37: e89. PMID 19474344 DOI: 10.1093/Nar/Gkp413  0.473
2009 Varadan V, Kamalakaran S, Russnes HG, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Lucito R, Wigler M, Dimitrova N, Naume B, et al. Genome-Wide DNA Methylation Profiles of Breast Tumors Reveal Loci Associated with Relapse Risk. Cancer Research. 69: 4046-4046. DOI: 10.1158/0008-5472.Sabcs-09-4046  0.484
2009 Kamalakaran S, Russnes HG, Janevski A, Levy D, Kendall J, Varadan V, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Lucito R, Wigler M, Dimitrova N, Naume B, et al. Subtype Dependent Alterations of the DNA Methylation Landscape in Breast Cancer. Cancer Research. 69: 1144-1144. DOI: 10.1158/0008-5472.Sabcs-09-1144  0.496
2008 Chen S, Auletta T, Dovirak O, Hutter C, Kuntz K, El-ftesi S, Kendall J, Han H, Von Hoff DD, Ashfaq R, Maitra A, Iacobuzio-Donahue CA, Hruban RH, Lucito R. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification. Cancer Biology & Therapy. 7: 1793-802. PMID 18836286 DOI: 10.4161/Cbt.7.11.6840  0.542
2008 Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biology & Therapy. 7: 1593-601. PMID 18769116 DOI: 10.4161/Cbt.7.10.6565  0.498
2008 Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes & Development. 22: 1439-44. PMID 18519636 DOI: 10.1101/Gad.1672608  0.439
2008 Degenhardt YY, Wooster R, McCombie RW, Lucito R, Powers S. High-content analysis of cancer genome DNA alterations. Current Opinion in Genetics & Development. 18: 68-72. PMID 18339543 DOI: 10.1016/J.Gde.2008.01.005  0.515
2007 Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, Sebat J, Wigler M, Klein AP, Brune K, Palmisano E, Maitra A, Goggins M, Hruban RH. Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biology & Therapy. 6: 1592-9. PMID 17912030 DOI: 10.4161/Cbt.6.10.4725  0.518
2007 Ivanov SV, Ivanova AV, Lucito R, Pass HI. PD6-2-8: High-resolution ROMA analysis of chromosomal rearrangements in mesothelioma patients with poor and good survival Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283338.44473.8A  0.348
2006 Pelham RJ, Rodgers L, Hall I, Lucito R, Nguyen KC, Navin N, Hicks J, Mu D, Powers S, Wigler M, Botstein D. Identification of alterations in DNA copy number in host stromal cells during tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 103: 19848-53. PMID 17167050 DOI: 10.1073/Pnas.0609635104  0.417
2006 Lakshmi B, Hall IM, Egan C, Alexander J, Leotta A, Healy J, Zender L, Spector MS, Xue W, Lowe SW, Wigler M, Lucito R. Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens. Proceedings of the National Academy of Sciences of the United States of America. 103: 11234-9. PMID 16844783 DOI: 10.1073/Pnas.0602984103  0.402
2006 Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 125: 1253-67. PMID 16814713 DOI: 10.1016/J.Cell.2006.05.030  0.536
2005 Zender L, Xue W, Cordón-Cardo C, Hannon GJ, Lucito R, Powers S, Flemming P, Spector MS, Lowe SW. Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harbor Symposia On Quantitative Biology. 70: 251-61. PMID 16869761 DOI: 10.1101/Sqb.2005.70.059  0.404
2005 Prawitt D, Enklaar T, Gärtner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, et al. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proceedings of the National Academy of Sciences of the United States of America. 102: 4085-90. PMID 15743916 DOI: 10.1073/Pnas.0500037102  0.326
2004 Daruwala RS, Rudra A, Ostrer H, Lucito R, Wigler M, Mishra B. A versatile statistical analysis algorithm to detect genome copy number variation. Proceedings of the National Academy of Sciences of the United States of America. 101: 16292-7. PMID 15534219 DOI: 10.1073/Pnas.0407247101  0.335
2004 Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (Oxford, England). 5: 557-72. PMID 15475419 DOI: 10.1093/Biostatistics/Kxh008  0.375
2004 Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, MÃ¥nér S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, et al. Large-scale copy number polymorphism in the human genome. Science (New York, N.Y.). 305: 525-8. PMID 15273396 DOI: 10.1126/Science.1098918  0.35
2004 Silva JM, Mizuno H, Brady A, Lucito R, Hannon GJ. RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 6548-52. PMID 15084744 DOI: 10.1073/Pnas.0400165101  0.351
2003 Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Research. 13: 2291-305. PMID 12975311 DOI: 10.1101/Gr.1349003  0.408
2002 Schmitz AA, Lucito R, Van Aelst L. Using cDNA-representational difference analysis (cDNA-RDA) in combination with microarrays to identify Rac regulated genes. Methods in Molecular Biology (Clifton, N.J.). 189: 25-43. PMID 12094592 DOI: 10.1385/1-59259-281-3:025  0.391
2001 Lucito R, Alexander J, Rostan S, West J, Wigler M. Detection of gene copy number fluctuations with microarrays using genomic representations Nature Genetics. 27: 70-70. DOI: 10.1038/87190  0.338
2000 Lucito R, West J, Reiner A, Alexander J, Esposito D, Mishra B, Powers S, Norton L, Wigler M. Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Research. 10: 1726-36. PMID 11076858 DOI: 10.1101/Gr.138300  0.406
1999 Lucito R, West J, Reiner A, Alexander J, Yen C, Nakamura M, Wigler M. Application of representational microarrays to genetic analysis of primary tumours Nature Genetics. 23: 60-60. DOI: 10.1038/14359  0.409
1998 Lucito R, Nakimura M, West JA, Han Y, Chin K, Jensen K, McCombie R, Gray JW, Wigler M. Genetic analysis using genomic representations. Proceedings of the National Academy of Sciences of the United States of America. 95: 4487-92. PMID 9539764 DOI: 10.1073/Pnas.95.8.4487  0.38
Show low-probability matches.